Dr Loretta Dorstyn
Senior Research Fellow
Centre for Cancer Biology
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Dr Loretta Dorstyn is a Senior Research Fellow and Project Leader at the Centre for Cancer Biology (CCB - UniSA and SA Pathology). Loretta has over 20 years experience in molecular and cellular biology and understanding of the fundamental process of programmed cell death (mostly apoptosis) during development and in disease. Loretta received her PhD from the University of Adelaide where she cloned and characterised two novel apoptosis enzymes (caspases) in the model organism and fruit fly, Drosophila melanogaster. She then spent 8 years studying the roles and mechanisms of caspases, including how they are activated and regulated during apoptosis. Over this time she was awarded a RAH Florey Fellowship that fostered her independent research where she initiated several apoptosis-related projects.
In 2012 she was awarded a South Australian Cancer Collaborative Senior Research Fellowship and transitioned to project leader at the CCB. Over this time, Loretta established several independent projects that focused on understanding how cell death mechanisms act to maintain cell homeostasis and genome integrity. Her projects led to numerous seminal findings detailing cell death mechanisms in tumour suppression, DNA damage repair, genomic stability, oxidative stress and healthy ageing. She has spent the last 10 years studying different mouse tumour models to better understand caspase regulation and roles in tumour suppression and has gained extensive expertise in tumour biology, as well as genomic, proteomic and bioinformatic analyses. Loretta's current work aims to understand how cells can evade checkpoint or “safety net” mechanisms during cell division and thereby acquire persistent DNA alterations and mutations. This phenomenon is known as genomic instability and is one of the key hallmarks ageing-related diseases such as cancer. Her current research focus is to understand how genomic instability increases with age and drives tissue damage, inflammation and age-related cancer including liver, gut and bone marrow cancers.
Tumour suppression by apoptotic Caspases
Caspases are the main enzymes that initiate and execute cell death by apoptosis. Our work has focussed on functional analysis of caspase-2, one of the first caspases discovered and has identified the apoptotic and non-apoptotic functions of this caspase. I was part of the team that described the function of caspase-2 in apoptosis induced by cytotoxic drugs that disrupt the cytoskeleton (Ho et al. 2008, Oncogene). This was followed by the first seminal demonstration that caspase-2 acts as a tumour suppressor in mice (Ho et al., 2009, Proc Natl Acad Sci USA). These findings led to further studies using various different mouse tumour models to define the role of caspase-2 in tumour suppression. In particular, the mouse thymoma model (Atm knockout mice) was used to demonstrate genetic interaction between Atm and caspase-2 in tumour suppression and enhanced tumour development in a caspase-2 knockout background (Puccini et al., 2013, Proc Natl Acad Sci USA). Interestingly, I also demonstrated that loss of caspase-2 can in fact delay tumour onset in a MYCN transgenic neuroblastoma mouse model (Dorstyn et al., 2014, Cell Death Dis). These findings indicated that caspase-2 has very defined tissue specific and context specific roles in tumour suppression and we are currently investigating the mechanisms by which it mediates these opposing functions.
Regulation of cellular stress pathways
- Caspase-2 function in genomic stability: My studies have demonstrated that loss of the caspase-2 gene leads to increased proliferation of primary fibroblasts, enhanced cell immortalisation and the accumulation of cells with DNA damage and aneuploidy (abnormal chromosome number) that drives genome instability (Dorstyn et al., 2012, Cell Death Differ). These studies also demonstrated that caspase-2 acts upstream of the tumour suppressor protein p53 in the DNA damage response pathway. Loss of caspase-2 significantly reduces p53 activation levels while stabilising c-Myc levels and our current work is aimed at understanding these roles. In further studies published in two recent papers (Dawar et al., 2017, Oncogene; Dawar et al., 2016, Cell Death Dis) we report that caspase-2 is essential for the efficient removal of cells carrying mitotic aberrations, especially those with abnormal nuclei or aneuploidy. We discovered that cells that lack caspase-2 have abnormal cell division “checkpoints” that normally prevent damaged cells from surviving and becoming aneuploid. As a consequence, ageing mice that are deficient in caspase-2 accumulate aneuploid cells in their tissues (e.g. bone marrow, spleen, liver) with ageing. These findings indicate that caspase-2 plays a critical role in preventing the long-term survival and growth of cells that could otherwise become malignant, thus proving a mechanism for tumour suppression by this caspase.
- Caspase-2 regulation of oxidative stress and ageing: In a paper published in Oncogene (Shalini et al., 2015), we demonstrated that caspase-2 deficiency exacerbates cellular stress in mice following low dose challenge with the potent reactive oxygen species (ROS) generator, paraquat (PQ). This was shown to be due to increased inflammation and impaired response to oxidative stress, including failure to upregulate the antioxidant defence mechanism in animals lacking caspase-2. Interestingly, we found that Casp2-/- mice exhibited more severe lung and liver lesions with extensive karyomegaly, a feature commonly associated with ageing and genomic instability. Thus, our work indicates that caspase-2 is critical in regulating the oxidative stress response and in preventing cellular stress and pre-mature ageing. We also made the direct demonstration that the absence of caspase-2 function and activity, accelerates oxidative stress-induced chronic liver cancer (hepatocellular carcinoma) as well as age-related chronic liver inflammation and HCC (Shalini et al., 2016, Cell Death Differ; Dorstyn et al., 2025 under review).
By preventing genomic instability and regulating the oxidative stress response, caspase-2 acts as a key cell surveillance protein and as a consequence is important to prevent tissue dysfunction and pre-mature ageing in mice. We are currently interested in understanding the molecular basis of these mechanisms in healthy ageing, maintaining normal tissue function and role in age-related diseases, including cancer.
| Date | Position | Institution name |
|---|---|---|
| 2022 - ongoing | Research Degree Coordinator | University of South Australia |
| 2012 - ongoing | Senior Research Fellow and Project Leader | University of South Australia |
| 2012 - 2015 | SACRC Senior Research Fellow | South Australia Pathology |
| 2009 - 2011 | Research Officer | South Australia Pathology |
| 2005 - ongoing | Affiliate Senior Lecturer | University of Adelaide |
| 2005 - 2008 | Royal Adelaide Hospital Florey Fellow | Royal Adelaide Hospital |
| 2001 - 2004 | Research Officer | Institute of Medical and Veterinary Sciences |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2012 | Fellowship | South Australian Cancer Research Collaborative Senior Research Fellowship | Cancer Council SA | Australia | - |
| 2005 | Fellowship | Royal Adelaide Hospital Florey Research Fellowship | Royal Adelaide Hospital | Australia | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 1997 - 2001 | University of Adelaide | Australia | PhD |
| 1996 - 1996 | University of Adelaide | Australia | BSc - Honours (First Class) |
| 1993 - 1995 | University of Adelaide | Australia | BSc |
| Year | Citation |
|---|---|
| 2014 | Dorstyn, L., & Kumar, S. (2014). Caspase-2 protocols. In P. Bozhkov, & G. Salvasen (Eds.), Caspases, paracaspases and metacaspases: methods and protocols (Vol. 1133, pp. 71-87). Humana Press. DOI Scopus6 Europe PMC7 |
| 2013 | Dorstyn, L., & Kumar, S. (2013). Insect Caspases. In N. Rawlings, & G. Salvesen (Eds.), Handbook of Proteolytic Enzymes, Volume 2 (Vol. 2, 3 ed., pp. 2286-2295). United Kingdom: Elsevier. DOI Scopus1 |
| 2005 | Dorstyn, L., & Kumar, S. (2005). Programmed cell death in drosophila melanogaster. In When Cells Die II A Comprehensive Evaluation of Apoptosis and Programmed Cell Death (pp. 79-97). Scopus1 |
| 1998 | Dorstyn, L. E., Kumar, S., & Kinoshita, M. (1998). Caspases in Cell Death. In S. Kumar (Ed.), Apoptosis: Mechanisms and Role in Disease (Vol. 24, pp. 1-24). Springer New York. DOI Scopus12 Europe PMC4 |
| Year | Citation |
|---|---|
| 2022 | Kumar, S., Lim, Y., & Dorstyn, L. (2022). Tumor and aneuploidy suppression by caspase-2. In CANCER SCIENCE Vol. 113 (pp. 1 page). WILEY. |
-
Deciphering the mechanisms of caspase-2-mediated suppression of aneuploidy and tumourigenesis, NHMRC - Project Grant, 01/01/2019 - 31/12/2021
-
Using mouse models to decipher the function of caspase-2 in limiting aneuploidy tolerance and cancer, NHMRC - Project Grant, 01/01/2018 - 30/06/2021
-
Deciphering the function of capcase-2 in DNA damage response and tumour suppression, NHMRC - Project Grant, 01/01/2014 - 31/12/2017
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Principal Supervisor | Exploring the mechanisms of age-related polyploidy in inflammation and liver cancer | Doctor of Philosophy | Doctorate | Full Time | Mr Manish Kumar Vuriti |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2012 - 2016 | Co-Supervisor | Characterisation of Pathophysiological Function of NEDD4-2 in Kidney | Doctor of Philosophy | Doctorate | Full Time | Mr Pranay Goel |
| 2010 - 2014 | Co-Supervisor | Characterisation of Caspase-2 Function in the DNA Damage Response and Tumour Suppression | Doctor of Philosophy | Doctorate | Full Time | Mr Joey Puccini |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2019 - 2023 | Member | Conference Organising Committee | Centre for Cancer Biology | Australia |
| 2014 - ongoing | Member | Centre for Cancer Biology Faculty | Centre for Cancer Biology | Australia |
| 2011 - ongoing | Member | NHMRC GRP | National Health and Medical Research Council | Australia |
| 2010 - ongoing | Member | F1000 Associate Member | Faculty of 1000 (United States) | United States |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2020 - ongoing | Member | Australasian Cell Death Society | - |
| 2012 - ongoing | Member | Australia and New Zealand Society for Cell and Developmental Biology | - |
| 2012 - ongoing | Member | Australian Society for Medical Research | - |
| 2002 - ongoing | Member | The Australian Society for Biochemistry and Molecular Biology | - |
| Date | Title | Engagement Type | Institution | Country |
|---|---|---|---|---|
| 2027 - 2017 | Researchers find link between common enzyme and cancer prevention | Scientific Community Engagement | Medical Xpress (online article) | Australia |
| 2014 - 2017 | Researcher Showcase Discussion Panel (Public Event) | Public Community Engagement | Cancer Council SA | Australia |
| 2009 - ongoing | Caspase-2 | Scientific Community Engagement | Springer Nature (United Kingdom) | United Kingdom |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2024 - ongoing | Member | Frontiers in Cell Death -Community reviewer for Inflammation and Cytotoxicity | Frontiers in Cell Death | United States |
| Date | Title | Type | Institution | Country |
|---|---|---|---|---|
| 2024 - ongoing | Grant Review | Grant Assessment | Swiss National Science Foundation | Switzerland |
| 2019 - ongoing | Grant Review | Grant Assessment | Health Research Council of New Zealand | New Zealand |
| 2018 - ongoing | Grant Review | Grant Assessment | National Science Foundation | United States |
| 2011 - ongoing | Grant Review | Grant Assessment | National Health and Medical Research Council | Australia |